Emerging experimental drugs in clinical trials for migraine: observations and key talking points-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging experimental drugs in clinical trials for migraine: observations and key talking points

Published:2023-08-03 Issue:8 Volume:32 Page:761-771
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Wells-Gatnik William David¹,Wences Chirino Tiffany Yazmin²,Onan Fatma Nur³,Onan Dilara⁴,Martelletti Paolo¹^ORCID

Affiliation:

1. Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy

2. Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

3. Faculty of Pharmacy, Ankara University, Ankara, Türkiye

4. Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Türkiye

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2254691

Reference112 articles.

1. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Systematic Review of Migraine Prophylaxis Adherence and Persistence

4. The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine

5. Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine;Expert Review of Neurotherapeutics;2024-09-12

2. Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis;The Journal of Headache and Pain;2024-04-10

3. Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial;The Journal of Headache and Pain;2024-03-25

4. New drugs targeting calcitonin gene-related peptide for the management of migraines;Expert Opinion on Emerging Drugs;2023-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3